Side-by-side comparison of AI visibility scores, market position, and capabilities
Richmond VA YC W20 on-demand senior companion platform with 1,000%+ pandemic revenue growth; $13.5M total ($9M Translink Series A 2022) connecting older adults with vetted Nabors for companionship, errands, and transportation competing with Papa.
Naborforce is a Richmond, Virginia-based on-demand senior companionship and assistance platform — backed by Y Combinator (W20) with approximately $13.5 million in total funding including a $9 million Series A in August 2022 led by Translink Capital with Claritas Capital, The Artemis Fund, and TechStars — providing older adults with on-demand access to a vetted network of 'Nabors' (friendly helpers who are not healthcare providers) for social engagement, companionship, errands, transportation, and light assistance around the home. Founded in 2016, Naborforce grew revenue over 1,000% and expanded its client base over 800% during the COVID-19 pandemic, demonstrating the pent-up demand for senior social connection and practical assistance services.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.